Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model
- 26 February 2019
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 68 (5) , 753-763
Abstract
The presence of IL-10, produced either by tumor cells or immunosuppressive cells, is frequently associated with a poor prognosis for cancer progression. It may also negatively impact anticancer treatments, such as immunotherapies, that otherwise would promote the activation of cytotoxic T cells capable of detecting and destroying malignant cells. In the present study, we evaluated a new adjuvant approach for anticancer immunotherapy using a plasmid vector encoding a soluble form of the IL-10 receptor (pIL-10R). pIL-10R was coadministered to mice with a DNA vaccine encoding the type 16 human papillomavirus (HPV-16) E7 oncoprotein genetically fused with glycoprotein D of herpes simplex virus (HSV) (pgDE7h). Immunization regimens based on the coadministration of pIL-10R and pgDE7h enhanced the antitumor immunity elicited in mice injected with TC-1 cells, which express HPV-16 oncoproteins. The administration of the DNA vaccines by in vivo electroporation further enhanced the anticancer effects of the vaccines, leading to the activation of tumor-infiltrating polyfunctional E7-specific cytotoxic CD8+ T cells and control of the expansion of immunosuppressive cells. In addition, the combination of immunotherapy and pIL-10R allowed the control of tumors in more advanced growth stages that otherwise would not be treatable by the pgDE7h vaccine. In conclusion, the proposed treatment involving the expression of IL-10R enhanced the antitumor protective immunity induced by pgDE7h administration and may contribute to the development of more efficient clinical interventions against HPV-induced tumors.Keywords
Funding Information
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo (2014/11073-1)
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo (2016/14344-1, 2016/11397-7, 2013/15360-2, 2015/16505-0, 2016/00708-1, 2011/51218-0)
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior (560713)
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (520931/1996-3, 308085/2015-9)
This publication has 37 references indexed in Scilit:
- The paradox of IL-10-mediated modulation in cervical cancerBiomedical Reports, 2013
- Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as ThievesJournal of Cancer, 2013
- Differential Impact of IL-10 Expression on Survival and Relapse between HPV16-Positive and -Negative Oral Squamous Cell CarcinomasPLOS ONE, 2012
- Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potencyClinical and Experimental Immunology, 2011
- Immune Responses and Therapeutic Antitumor Effects of an Experimental DNA Vaccine Encoding Human Papillomavirus Type 16 Oncoproteins Genetically Fused to Herpesvirus Glycoprotein DClinical and Vaccine Immunology, 2010
- A tritherapy combination of a fusion protein vaccine with immune‐modulating doses of sequential chemotherapies in an optimized regimen completely eradicates large tumors in miceInternational Journal of Cancer, 2010
- How Tolerogenic Dendritic Cells Induce Regulatory T Cells2010
- Self-antigen–specific CD8+ T cell precursor frequency determines the quality of the antitumor immune responseJournal of Experimental Medicine, 2009
- Correlation Between IL-10 Gene Expression and HPV Infection in Cervical Cancer: A Mechanism for Immune Response EscapeCancer Investigation, 2008
- Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responsesJournal of Experimental Medicine, 2007